Medpace director receives 1,110 stock options
Medpace Holdings, Inc. director Robert O. Kraft reported a new stock option award and his current share holdings.
Rhea-AI Filing Summary
Medpace Holdings, Inc. director Robert O. Kraft reported a new stock option award and his current share holdings. He received options to buy 1,110 shares of common stock at an exercise price of $415.27 per share, expiring on May 15, 2033. Following the award, he holds 922 shares of common stock directly. The option vests on the earlier of the day immediately before the first annual meeting after the grant date or the first anniversary of the grant date, subject to his continued service on the board.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,110 shares
Grant/Award
2 txns
Insider
Kraft Robert O.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 1,110 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 1,110 contracts (Direct);
Common Stock — 922 shares (Direct)
Footnotes (1)
- F1. The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting of the Issuer following the date of grant, and (ii) the first anniversary of the date of grant, subject to continued service on the board of directors of the Issuer through the vesting date.
Key Figures
Option shares granted: 1,110 shares
Option exercise price: $415.27 per share
Option expiration: May 15, 2033
+1 more
4 metrics
Option shares granted
1,110 shares
Stock Option (Right to Buy) grant on May 15, 2026
Option exercise price
$415.27 per share
Exercise price for 1,110 stock options
Option expiration
May 15, 2033
Expiration date of granted stock options
Common shares held
922 shares
Direct holdings after reported transactions
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, exercise price, vesting
4 terms
Stock Option (Right to Buy) financial
"security_title": "Stock Option (Right to Buy)""
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
exercise price financial
"conversion_or_exercise_price": "415.2700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The option vests on the earlier of (i) the day immediately preceding the date of the first annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Medpace (MEDP) director Robert O. Kraft report?
Robert O. Kraft reported receiving a new stock option grant. The award covers 1,110 shares of Medpace common stock and is structured as a compensation-related option, not an open-market share purchase or sale.
How many Medpace (MEDP) stock options were granted to Robert O. Kraft and at what price?
He was granted options for 1,110 shares of Medpace common stock. These options have an exercise price of $415.27 per share, meaning he can buy shares at that price when the options are exercised.
When do Robert O. Kraft’s new Medpace (MEDP) stock options vest?
The options vest on the earlier of two dates. Vesting occurs either the day immediately before the first annual shareholder meeting after the grant date, or on the first anniversary of the grant, if board service continues.
What is the expiration date of Robert O. Kraft’s Medpace (MEDP) stock options?
The granted stock options expire on May 15, 2033. After that date, any unexercised portion of the 1,110-share option award will lapse and can no longer be exercised at the $415.27 strike price.
Is Robert O. Kraft’s Medpace (MEDP) Form 4 transaction an open-market buy or sell?
The filing shows a grant of stock options, not an open-market trade. The transaction is coded as a grant or award, indicating compensation rather than a discretionary purchase or sale of Medpace common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
